A detailed history of Quadrant Capital Group LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Quadrant Capital Group LLC holds 9,562 shares of TAK stock, worth $132,433. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,562
Previous 15,123 36.77%
Holding current value
$132,433
Previous $210,000 41.43%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$12.6 - $13.67 $70,068 - $76,018
-5,561 Reduced 36.77%
9,562 $123,000
Q1 2024

May 15, 2024

SELL
$13.89 - $15.04 $29,169 - $31,584
-2,100 Reduced 12.19%
15,123 $210,000
Q4 2023

Feb 08, 2024

SELL
$13.36 - $15.43 $33,480 - $38,667
-2,506 Reduced 12.7%
17,223 $245,000
Q3 2023

Nov 14, 2023

SELL
$15.03 - $16.32 $66,823 - $72,558
-4,446 Reduced 18.39%
19,729 $305,000
Q2 2023

Aug 09, 2023

SELL
$15.57 - $17.11 $44,000 - $48,352
-2,826 Reduced 10.47%
24,175 $379,000
Q1 2023

May 11, 2023

BUY
$15.28 - $16.48 $122,866 - $132,515
8,041 Added 42.41%
27,001 $444,000
Q4 2022

Feb 10, 2023

SELL
$12.42 - $15.62 $1,776 - $2,233
-143 Reduced 0.75%
18,960 $295,000
Q3 2022

Nov 10, 2022

BUY
$12.8 - $28.65 $15,539 - $34,781
1,214 Added 6.79%
19,103 $248,000
Q2 2022

Aug 09, 2022

SELL
$13.12 - $15.03 $27,801 - $31,848
-2,119 Reduced 10.59%
17,889 $251,000
Q1 2022

May 06, 2022

BUY
$13.54 - $15.35 $37,952 - $43,026
2,803 Added 16.29%
20,008 $287,000
Q4 2021

Feb 01, 2022

BUY
$13.17 - $16.4 $126,721 - $157,800
9,622 Added 126.89%
17,205 $235,000
Q3 2021

Nov 12, 2021

SELL
$16.3 - $17.26 $53,284 - $56,422
-3,269 Reduced 30.12%
7,583 $124,000
Q2 2021

Aug 09, 2021

BUY
$16.55 - $18.64 $6,222 - $7,008
376 Added 3.59%
10,852 $183,000
Q1 2021

May 12, 2021

BUY
$16.71 - $19.9 $18,865 - $22,467
1,129 Added 12.08%
10,476 $191,000
Q4 2020

Feb 16, 2021

SELL
$15.39 - $18.97 $32,488 - $40,045
-2,111 Reduced 18.42%
9,347 $170,000
Q3 2020

Nov 13, 2020

BUY
$17.1 - $19.19 $68,092 - $76,414
3,982 Added 53.26%
11,458 $204,000
Q2 2020

Aug 13, 2020

SELL
$14.59 - $19.5 $638,341 - $853,164
-43,752 Reduced 85.41%
7,476 $134,000
Q1 2020

May 15, 2020

SELL
$13.02 - $20.31 $10,962 - $17,101
-842 Reduced 1.62%
51,228 $779,000
Q4 2019

Feb 03, 2020

BUY
$16.88 - $20.83 $348,690 - $430,285
20,657 Added 65.76%
52,070 $1.01 Million
Q3 2019

Oct 24, 2019

BUY
$16.15 - $17.99 $4,489 - $5,001
278 Added 0.89%
31,413 $532,000
Q2 2019

Jul 24, 2019

BUY
$16.58 - $20.49 $116,905 - $144,474
7,051 Added 29.28%
31,135 $543,000
Q1 2019

Apr 29, 2019

BUY
$16.7 - $21.52 $182,731 - $235,471
10,942 Added 83.26%
24,084 $476,000
Q4 2018

Jan 17, 2019

BUY
$15.64 - $21.1 $172,994 - $233,387
11,061 Added 531.52%
13,142 $216,000
Q3 2018

Oct 29, 2018

SELL
$19.54 - $21.81 $3,908 - $4,362
-200 Reduced 8.77%
2,081 $37,000
Q2 2018

Aug 09, 2018

SELL
$18.98 - $24.95 $78,273 - $102,893
-4,124 Reduced 64.39%
2,281 $40,000
Q1 2018

May 10, 2018

SELL
$24.41 - $30.74 $1,025 - $1,291
-42 Reduced 0.65%
6,405 $149,000
Q4 2017

Jan 31, 2018

SELL
$26.96 - $28.56 $269 - $285
-10 Reduced 0.15%
6,447 $176,000
Q3 2017

Oct 13, 2017

BUY
$26.6 - $28.23 $11,571 - $12,280
435 Added 7.22%
6,457 $172,000
Q2 2017

Aug 15, 2017

BUY
N/A
6,022
6,022 $143,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.